MinichMacGregor Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.5M Buy
78,396
+76,106
+3,323% +$15.3M 2.66% 11
2026
Q2
$436K Buy
+2,290
New +$394K 0.07% 88
2024
Q4
– Sell
-1,519
Closed -$221K – 124
2024
Q3
$221K Buy
+1,519
New +$220K 0.05% 107
2023
Q1
– Sell
-801
Closed -$105K – 326
2022
Q4
$105K Buy
+801
New +$104K 0.04% 111
2021
Q2
– Sell
-2,743
Closed -$412K – 81
2021
Q1
$412K Buy
2,743
+81
+3% +$12.9K 0.15% 57
2020
Q4
$403K Sell
2,662
-15,367
-85% -$2.2M 0.16% 55
2020
Q3
$2.44M Sell
18,029
-32,251
-64% -$4.38M 1.15% 23
2020
Q2
$6.87M Buy
+50,280
New +$6.41M 3.8% 8
2019
Q1
– Sell
-4,541
Closed -$1.52M – 80
2018
Q4
$1.52M Buy
4,541
+3,335
+277% +$354K 1.04% 35
2018
Q3
$146K Hold
1,206
– – 0.1% 54
2018
Q2
$133K Sell
1,206
-12
-1% -$1.28K 0.09% 59
2018
Q1
$130K Sell
1,218
-200
-14% -$22.2K 0.1% 55
2017
Q4
$151K Sell
1,418
-88
-6% -$9.41K 0.12% 50
2017
Q3
$167K Buy
1,506
+75
+5% +$8.02K 0.14% 43
2017
Q2
$147K Sell
1,431
-75
-5% -$7.39K 0.13% 49
2017
Q1
$147K Buy
1,506
+300
+25% +$28.7K 0.13% 47
2016
Q4
$106K Buy
1,206
+132
+12% +$12K 0.1% 58
2016
Q3
$103K Hold
1,074
– – 0.1% 59
2016
Q2
$92K Hold
1,074
– – 0.09% 72
2016
Q1
$93K Sell
1,074
-34,110
-97% -$3.05M 0.09% 69
2015
Q4
$4.28M Buy
+35,184
New +$3.82M 3.99% 6

Other funds holding IBB

MinichMacGregor Wealth Management's IBB Position: Q3 2026 in Review

MinichMacGregor Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 3,323% in Q3 2026, buying an estimated $15.3M and bringing the position to 78,396 shares worth $16.5M. The position accounts for 2.66% of the portfolio, ranked #11.

MinichMacGregor Wealth Management first reported a position in IBB in Q4 2015 and has held it in 21 quarters since. 434 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • MinichMacGregor Wealth Management held 78,396 shares of iShares Biotechnology ETF worth $16.5M as of Q3 2026.
  • MinichMacGregor Wealth Management bought 76,106 iShares Biotechnology ETF shares in Q3 2026, an estimated $15.3M.
  • iShares Biotechnology ETF made up 2.66% of MinichMacGregor Wealth Management's portfolio in Q3 2026, its #11 holding.
  • MinichMacGregor Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 21 quarters since.
  • 434 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.